Parse Biosciences, a leader in accessible and scalable single cell sequencing solutions, today ...

On January 27, in Apple Inc. v. Gesture Technology Partners, LLC, the Federal Circuit held that the Patent Trial and Appeal ...

The US Patent and Trademark Office told a group of specialized patent judges on Tuesday afternoon they could be expected to ...

On, January 27, 2025, the United States Court of Appeals for the Federal Circuit affirmed-in-part and reversed-in-part a decision from the ...

Seattle-based Parse Biosciences secured another major legal victory in its patent dispute with 10x Genomics Inc. (Nasdaq: TXG ...

This week we speak with Scott McKeown, who is a shareholder at Wolf Greenfield and one of the leading U.S. PTAB practitioners ...

Congress began hearing that the patent system needed a faster, cheaper way than district court suits to assess the validity ...

If Trump’s prior presidential term serves as any indication of what is to come, we can expect to see several significant ...

Atossa Therapeutics, Inc. expressed disappointment over the Patent Trial and Appeal Board's ruling deeming all challenged claims of U.S. Patent No. 11,572,334 unpatentable. While Atossa will not ...

SEATTLE, Jan. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment of breast cancer, today ...

This week, hearings set before the Federal Court of Appeal and the Federal Court included matters relating to a Canadian ...